International Stem Cell Corp. (OTCMKTS:ISCO – Get Free Report) shares crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.14 and traded as high as $0.1520. International Stem Cell shares last traded at $0.1465, with a volume of 7,218 shares changing hands.
International Stem Cell Price Performance
The firm has a market cap of $1.17 million, a price-to-earnings ratio of -3.66 and a beta of -0.02. The firm has a 50 day moving average price of $0.14 and a 200-day moving average price of $0.14.
International Stem Cell (OTCMKTS:ISCO – Get Free Report) last issued its quarterly earnings results on Thursday, August 14th. The biotechnology company reported $0.01 earnings per share (EPS) for the quarter. The firm had revenue of $2.45 million for the quarter.
About International Stem Cell
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Further Reading
- Five stocks we like better than International Stem Cell
- Buy P&G Now, Before It Sets A New All-Time High
- Why Microsoft’s Post-Earnings Dip Is a Buy-the-Pause Moment
- The Most Important Warren Buffett Stock for Investors: His Own
- NVIDIA’s Billion-Dollar Bet Puts Nokia Back in the Growth Game
- 3 Stocks to Consider Buying in October
- Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
